Zoetis Inc. is under investigation by Pomerantz LLP for potential securities fraud following its May 7, 2026, announcement of flat Q1 net income and a lowered full-year profit forecast. The company reported $601 million in net income, unchanged from last year, but cut its 2026 earnings guidance to $6.85-$7.00 per share from $7.00-$7.10. CEO Kristin Peck cited a tougher market with more price-sensitive pet owners and reduced veterinary visits. Zoetis's stock price fell sharply by 21.5%, prompting the legal probe into whether the company and its executives engaged in unlawful practices.
Barron's May 2026 investment tips feature 20 stocks, 11 considered 'safer' due to free cash flow yields exceeding dividend yields. The top ten by yield are expected to deliver an average net gain of 36.08% by May 2027 with 24% less volatility than th...
Zoetis Inc. shares dropped about 21.5% on May 7, 2026, after the company lowered its full-year 2026 revenue guidance, citing weaker demand in the U.S. pet-care market, macroeconomic pressures, and increased competition. This sharp decline followed th...
Zoetis CEO initially forecasted 3%-5% organic revenue growth for 2026, expecting gradual macroeconomic improvement. However, the company cut its full-year revenue guidance after missing Q1 results, causing shares to drop about 21.5% on May 7, 2026. I...
